Intellia Therapeutics
NTLA
#5607
Rank
A$2.05 B
Marketcap
A$14.63
Share price
1.65%
Change (1 day)
12.73%
Change (1 year)

EPS for Intellia Therapeutics (NTLA)

EPS in 2026 (TTM): A-$4.96

According to Intellia Therapeutics's latest financial reports the company's current EPS (TTM) is A-$4.99. In 2025 the company made an earnings per share (EPS) of A-$5.68 an increase over its 2024 EPS that were of A-$7.79.

EPS history for Intellia Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$4.96-12.76%
2025A-$5.68-27.05%
2024A-$7.79-2.96%
2023A-$8.03-12.46%
2022A-$9.1764.36%
2021A-$5.5856.67%
2020A-$3.56
2018A-$2.956.99%
2017A-$2.7671.4%
2016A-$1.61

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
A-$2.00-59.82%๐Ÿ‡บ๐Ÿ‡ธ USA